#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Acquired C1 inhibitor deficiency Follicular lymphoma stage III Squamous cell carcinoma of the vulva Hypersensitivity pneumonitis Neurofibromatosis Round cell liposarcoma Intracranial calcification Adenocarcinoma gastric Cutaneous T-cell lymphoma Thermal burn Immunoglobulin G4 related disease Choroid melanoma Glioblastoma Erythema multiforme More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Treatment Mucopolysaccharidosis III – Trials in Disease Gaucher’s disease type I – Life with Disease Systemic mastocytosis – Basic Information Loeys-Dietz syndrome – Life with Disease Osteosarcoma metastatic – Treatment Prolymphocytic leukaemia – Diagnostics Immunodeficiency congenital – Diagnostics Cystic fibrosis lung Testicular leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tin816 Darolutamide Vesleteplirsen Cibotercept RIMIDUCID SOFOSBUVIR Art6043 Montelukast Phenol [18F] CANAGLIFLOZIN Mepolizumab Hydroxycarbamide Hydrocortisone Acetate Ketamine GSK5458514 ANERATRIGINE MESILATE Risedronate Sodium Mrna-4157 Ibuprofen Ranolazine More therapies…

    Learn about Your Condition

    Phaeochromocytoma Overweight Hand dermatitis Colon cancer metastatic H1N1 influenza Bone hypertrophy Wolfram syndrome Renal cancer stage IV Rectal neoplasm Adenosquamous cell lung cancer Rectal cancer Advanced systemic mastocytosis Turner's syndrome Lung cancer metastatic Spondylolisthesis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Angelman’s syndrome
    Investigated Drugs:
    • Calcium Chloride
    • DISODIUM PHOSPHATE
    • Glucose, Anhydrous
    France Germany Spain

  • Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Rectal cancer
    Investigated Drugs:
    • Cetuximab
    • Encorafenib
    France

  • Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein
    • Human Papillomavirus Type 16 L1 Protein
    • Human Papillomavirus Type 18 L1 Protein
    Sweden

  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    • Systemic lupus erythematosus
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Auto4
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    • Rituximab
    Spain

  • Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Art6043
    • Olaparib
    Spain

  • Study on the Effects of Botulinum Toxin Type A and a Drug Combination on Rectal Function in Patients with Fecal Incontinence

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal incontinence
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Macrogol 3350
    • Sodium Ascorbate
    France
Previous Page
1 … 314 315 316 317 318 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!